BIOMAT Database Logo BIOMAT Database Logo

The effect of repeated oral doses of azelastine hydrochloride on antipyrine half-life in normal volunteers. 1988

A Johnston, and S J Warrington, and P Turner, and R Aurich
Department of Clinical Pharmacology, St. Bartholomew's Hospital, London, UK.

Treatment with azelastine 4.4 mg twice daily for 21 days did not produce any change in salivary antipyrine elimination in 8 normal volunteers.

UI MeSH Term Description Entries
D008297 Male Males
D010793 Phthalazines Bicyclic heterocyclic compounds containing a BENZENE ring fused to PYRIDAZINE.
D011724 Pyridazines Six-membered rings with two adjacent nitrogen atoms also called 1,2-diazine.
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006634 Histamine H1 Antagonists Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. Antihistamines, Classical,Antihistaminics, Classical,Antihistaminics, H1,Histamine H1 Antagonist,Histamine H1 Receptor Antagonist,Histamine H1 Receptor Antagonists,Histamine H1 Receptor Blockaders,Antagonists, Histamine H1,Antagonists, Histamine H1 Receptor,Antihistamines, Sedating,Blockaders, Histamine H1 Receptor,First Generation H1 Antagonists,H1 Receptor Blockaders,Histamine H1 Blockers,Receptor Blockaders, H1,Antagonist, Histamine H1,Classical Antihistamines,Classical Antihistaminics,H1 Antagonist, Histamine,H1 Antagonists, Histamine,H1 Antihistaminics,Sedating Antihistamines
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000983 Antipyrine An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29) Phenazone,Anodynin,Pyramidone
D012463 Saliva The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin. Salivas

Related Publications

A Johnston, and S J Warrington, and P Turner, and R Aurich
The effect of repeated oral doses of lornoxicam on antipyrine elimination in normal human volunteers.
September 1991, Human & experimental toxicology,
A Johnston, and S J Warrington, and P Turner, and R Aurich
Tolerability and pharmacokinetics of single and multiple doses of azelastine hydrochloride in elderly volunteers.
May 1995, Arzneimittel-Forschung,
A Johnston, and S J Warrington, and P Turner, and R Aurich
Increased antipyrine half-life in women taking oral contraceptives.
December 1970, Scottish medical journal,
A Johnston, and S J Warrington, and P Turner, and R Aurich
Pharmacokinetics of repeated single oral doses of enalapril maleate (MK-421) in normal volunteers.
January 1984, Biopharmaceutics & drug disposition,
A Johnston, and S J Warrington, and P Turner, and R Aurich
Antipyrine half-life in hyperthyroidism.
April 1981, East African medical journal,
A Johnston, and S J Warrington, and P Turner, and R Aurich
The plasma half-life of antipyrine in chromic uraemic and normal subjects.
August 1975, British journal of clinical pharmacology,
A Johnston, and S J Warrington, and P Turner, and R Aurich
Pharmacokinetics of rufloxacin in healthy volunteers after repeated oral doses.
January 1991, Chemotherapy,
A Johnston, and S J Warrington, and P Turner, and R Aurich
Environmental effects on antipyrine half-life in man.
November 1977, Clinical pharmacology and therapeutics,
A Johnston, and S J Warrington, and P Turner, and R Aurich
Multiple oral doses of diazepam, oxazepam and phenobarbital to dogs--behavioural effects and correlation with antipyrine half-life.
January 1977, Acta pharmacologica et toxicologica,
A Johnston, and S J Warrington, and P Turner, and R Aurich
Effects of repeated doses of scopolamine on the electroencephalographic stages of sleep in normal volunteers.
December 1975, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!